COVID-19 pandemic and "survival of the fittest".


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 10 2021
Historique:
received: 15 07 2020
accepted: 19 08 2021
entrez: 15 11 2021
pubmed: 16 11 2021
medline: 25 11 2021
Statut: epublish

Résumé

Occurrence and recurrence of COVID-19 cases have been observed globally. The complex relationship of host-pathogen and the environment plays a vital role in understanding the widespread recurrence of the SARS-CoV-2 among humans. Though the pathobiology of the disease is not completely understood, it is well established that COVID-19 poses a greater threat to individuals with co-morbidities and a weakened immune system. The article deals with the notion of innate immunity, natural selection, and the survival of the fittest during the COVID-19 outbreak. The article also attempts to introduce the concept of "lifestyle and cultural immunity" that needs to be addressed and incorporated at an early stage of childhood to boost up the human immune system. The communication further discusses the role of vaccination and micro-organisms pre-existing in the environment which are required to enhance the immunity of an individual.

Identifiants

pubmed: 34780359
doi: 10.3855/jidc.13490
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1384-1387

Informations de copyright

Copyright (c) 2021 Richa Mukhra, Kewal Krishan, Tanuj Kanchan.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Richa Mukhra (R)

Department of Anthropology, Panjab University, Chandigarh, India.

Kewal Krishan (K)

Department of Anthropology, Panjab University, Chandigarh, India. gargkk@yahoo.com.

Tanuj Kanchan (T)

Department of Forensic Medicine and Toxicology, All India Institute of Medical Sciences, Jodhpur, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH